Introduction to Pharmacokinetic Modelling Rationale
|
|
- Domenic Cross
- 5 years ago
- Views:
Transcription
1 Introduction to Pharmacokinetic Modelling Rationale Michael Weiss Martin Luther University Halle-Wittenberg
2 Philippus von Hohenheim, known as Paracelsus ( ) Everything is a poison... the dose differentiates a poison from a remedy.
3 1937 Archives internationales de pharmacodynamie et de therapie
4 Where the word pharmacokinetics first appeared 1953 This means that the principles governing plasma time-concentrations are not only capable of a mathematical adaptation, but are expected to undergo an advancement through the application of the powerful resources of mathematics.
5 Question 1
6 Question 2 The maximum plasma concentration immediatly (1 min) after a bolus dose of 1 mg digoxin is > 200 ng/ml. Is this dose toxic in view of the therapeutic window (target concentration) of ng/ml (toxicity > 2 ng/ml)? Question 3 When will be more than 90% of this dose be elimitated? CL = 0.2 l/min, V ss = 600 l
7 PK/PD Dose Pharmacokinetics Pharmacodynamics Effect Renal failure Effect Dosis Time Effect Receptor- Upregulation Dosis Time
8 Pharmacokinetic(PK)- Pharmacodynamic(PD) systems analysis Pharmacokinetics Pharmacodynamics Receptor binding & signal transduction PK/PD Pharmacometrics Variability Sparse data Clinical trial simulation Physiologically based (mechanistic) modeling Alterations in diseased states Disease progression Translational PK/PD modeling
9 Pharmacokinetic system Data Model structure Modeling methodology Parameter estimation Modeling purpose Model Cobelli and Carson, 2005
10 Systems Approach Disturbance Input Dose System Output C(t)
11 Pragmatic Validity Behavioural model empirical Heuristic Validity Structural model physiological/mechanistic 2 Black Box 1 Linear system theory Neural network Prediction +Explanation
12 Pharmacodynamics Pharmacokinetics Pharmacy Oral Drug Dose Dissolution sc, im, nasal, pulmonary, transdermal Absorption Distribution Elimination Metabolismn Excretion Effect Site (Receptors) Pharmacological Effect
13 Structure of pharmacokinetic system
14 Pharmacokinetics = Transport with flowing blood Transport across membranes
15 Passive Transport Small Molecules Perfusion or barrier limited Blood Large Molecules Severely permeability limited Blood Tissue Lymph Tissue
16 Active Transport P-Glycoprotein Pump (MDR1) intestine blood-brain barrier kidney liver testis cancer cells (MDR1) etc.
17 Transporter in PK OATPs MDR1 OATs BLOOD BRAIN BARRIER Heart-Lung LIVER BILE MRP2 MDRs MRP3 BSEP OCT1 OATPs OATs MRP3 MRP1 MRP2 MDR1 GUT OATPs OATPs MDR1 MRP2 OATs OCTs OATP: Organic AnionTransporting Polypeptide OAT: Organic Anion Transporter OCT: Organic Cation Transporter MDR: Multidrug Resistance protein MRP: Multidrug Resistance-associated Protein BSEP: Bile Salt Export KIDNEY
18 Metabolism drug metabolite enzymes
19 Diffusion C 1 C 2 da ( t) 1 P S[ C1( t) C2( t )] dt permeability surface da ( t) 1 CL C1( t perm ) dt rate Active Transport V C da1 ( t) max 1 dt K M C1 C 1
20 Plasma Digoxin Concentration (ng/ml) First Principles Based Modeling 3 2 Fit: 3-compartment model 3-exponential function ?? Initial phase < 5 min Time (h) Terminal phase t
21 First Principles Convective transport Convective dispersion Vascular mixing Permeation (Capillary uptake) Diffusion (Extravascular) Not well-mixed! Binding
22 Models of process PK Structural model Compartments (differential equations) Model independent (numerical integration) Subsystems (Laplace transformation) Models of data Statistics Intra- and inter-individual variability Probability distribution of the model parameters in the target population (population approach) Covariates NONMEM ADAPT 5 MONOLIX, etc Poor data perfect model poor result Poor model perfect data poor result
23 Model building Design of PK experiments Feasibility Identifiability
24 Pharmacokinetic System and Experimental Designs Compartmental Isolated perfused organ Destructive sampling PBPK C(t surgery ) In vivo Cardiac output Pulmonary Transit Time Density Systemic Transit Time Density
25 Veins Arteries Lung Structure of the body Brain Routes of drug administration Heart intra venous Kidney Testes Fat Muscle intramuscular oral (enteral) Dose D or, D iv etc. Liver Gut Spleen Organs of drug elimination Pancreas Skin Bone
26 Veins Arteries Lung What can we measure? Brain Heart Kidney Testes Fat Muscle Renal excretion (?) A er (t) Liver Gut Spleen Pancreas Venous blood (plasma) concentration C(t) Skin Bone
27 Modelling of PK transport in terms of mass (amount)! ( Transport or elimination of concentration is nonsense.) Dilemma: we measure concentration. C(t)? A(t)
28 Basic Equation da ( t) e dt CL C( t) Rate of drug elimination = Clearance x Plasma concentration model independent or noncompartmental analysis) (1) 0 dae ( t) A e CL C( t) dt dt 0 D iv CL AUC Well-mixed plasma compartment! Note: A ( ) D (nothing remains in the body) e iv
29 Estimation of Clearance (single dose) CL D iv Intravenous dose AUC Area Under the Curve C(t) Single dose AUC! D iv t AUC C ( t) dt 0
30 Estimation of Clearance (infusion) Steady state after continuous i.v. infusion Elimination rate Dose rate CL C ss DR C(t) Output (elimination rate) = Input (dose rate, infusion rate) C ss CL DR C ss DR t
31 Nonlinear Pharmacokinetics AUC linear nonlinear Dose
32 Saturable Metabolism R H Michaelis-Menten equation R H V K max M C C H, u H, u C(t) C H, u K saturation M C H, u CL int CL Vmax K M C H int V max K M, u linear (dose independent) kinetics exponential high bolus dose
33 Compartmental Models Compartmental Isolated perfused organ Destructive sampling PBPK C(t surgery ) In vivo Cardiac output Pulmonary Transit Time Density Systemic Transit Time Density
34 2-Compartment Model 2 peripheral compartm. V ss V 1 V2 V1 k ( 1 k12 21) k 12 k 21 D iv k 10 1 sampling (central) compartm. V0 V 1 dx1 ( t) dt dx2( t) dt k k x 1 x ( t) k 2 12 ( t) k 12 x 1 x ( t) 1 ( t) k 21 x 2 ( t) x 1 (0) = D iv C( t) x V 1 ( t) 1 reparameterisation k 10 CL V 1 k 12 CL V 1 d k 21 CL V 2 d
35 Distribution Kinetics t ~ 2-10 h Terminal half-life t 1/ 2,z
36 3-Compartment Model Fit excellent for C iv (t) of most drugs-useful as empirical model 2 V 1 : no clear meaning in terms of initial distribution D iv CL 12 V 1 1 CL CL 12, CL 21 : no meaning in terms of underlying distribution processes CL 13 3 Estimation and interpretation of steady-state parameters (CL, V ss ) is straightforward: V ss, CL model independent
37 Physiological Based Pharmacokinetic Modelling Compartmental Isolated perfused organ Destructive sampling PBPK C(t surgery ) In vivo Cardiac output Pulmonary Transit Time Density Systemic Transit Time Density
38 Veins Arteries Lung Brain Physiological Based Pharmacokinetic Modelling (PBPK) Heart Kidney V 2 Testes Fat Flow Q V 1 CL d CL d = f u PS Q Muscle Liver Gut Spleen Organ tissue volume V T Partition coefficient K Vascular volume V 1 V 2 = KV T Pancreas Skin Carcass
39 Veins Arteries Lung PBPK System of Diffeq Brain Heart Kidney Testes e.g., noneliminating organ: dx1 ( t) dt dx2( t) dt Q V 1 CL V x ( t) 2 d 1 x 2 CL V ( t) 1 d CL V x ( t) 1 1 d x ( t) 1 CL V 2 d x 2 ( t) Fat Muscle V 2 Liver Gut Spleen Flow Q V 1 CL d CL d = f u PS Q Pancreas Organ tissue volume V T Skin Partition coefficient K V 2 = KV T Carcass Vascular volume V 1
40 Simulation of Alfentanil Kinetics in Humans Upscaling from rat data Bjorkman, Wada, Stanski Anesthesiology, Human: Tissue volumes (mass) Vascular volumes Blood flows Rat: Partition coefficients Permeabilities (CL d )
41 Upscaling from Animal to Human P a p W CL a CL W b p Since Q L and GFR ~ W Organ function ~ V ss a MDRT V W a MDRT W W b Allometrie 0.25 BSA a BSA W 0.75 Alternatively: CL human CL animal Q Q L, human L, animal
42 Distributed Modelling Normalized outflow concentration Vascular marker Transit Time Distribution Advection-Dispersion Equation (Microvascular Network) C t D 2 C 2 x v C x Dispersion Coefficient (geometrical dispersion) Blood Flow Velocity
43 Solution of Advection-Dispersion Equation: Inverse Gaussian distribution, density f IG (t) (Brownian passage time distribution) Vascular Marker f(t) t t 2 C MTT ( t MTT ) ( t) f ( t) exp IG RD t 2RD 2 MTT t Mean transit time (MTT) Transit time dispersion (RD 2 ) Extent of distribution (V B = MTT Flow) Rate of distribution
44 Subsystems (Transit Time Distribution) Compartmental Isolated perfused organ Destructive sampling PBPK C(t surgery ) In vivo Cardiac output Pulmonary Transit Time Density Systemic Transit Time Density
45 Subsystems Model Formulation in the Laplace Domain Model Structure: Compartments Differential Equations Subsystems Transit Time Density Functions, f i (t) (Impulse Response) Limitation of using compartments as subsystems exponential distributed transit times Advantage of model building in Laplace domain simple rules for connecting subsystems
46 Model building: Laplace Transformation ) ( ˆ2 s f ) ( ˆ1 s f ) ( ˆ1 s f ) ( ˆ2 s f Q Q Q 1 Q 2 ) ˆ( ) ( ) ( ˆ ) ( ˆ ) ˆ( s f L t f s f s f s f ) ˆ( ) ( ) ( ˆ ) (1 ) ( ˆ ) ˆ( s f L t f Q Q q s f q s qf s f Numerical inverse Laplace transformation
47 Numerical Inverse Laplace Transformation f ( t) L 1 { fˆ( s)} Model Equation in Laplace Domain fˆ ( s) L{ f ( t)} Implemented in nonlinear regression software: SCIENTIST 3.0 ADAPT Schalla & Weiss, Eur J Pharm Sci,1999. FORTRAN implementation of Talbot's method
48 Recirculatory Model Compartmental Isolated perfused organ Destructive sampling PBPK C(t surgery ) In vivo Cardiac output Pulmonary Transit Time Density Systemic Transit Time Density
49 Initial Distribution (Front-End Kinetics) Thiopental 3-fold higher V C Determines the anesthetic induction dose! Using Front-end Kinetics to Optimize Target-controlled Drug Infusions Avram & Krejcie, Anesthesiology, 2003
50 Veins Arteries Minimal Circulatory Model Lung Pulmonary Dose C(t) Brain Heart Kidney Testes Fat Muscle Gut Lumping Dose Cardiac output Systemic C(t) Liver Spleen Pancrea s Skin Carcass
51 Hepatic Clearance C out CL Q H H E H Q H = 1500 ml/min F H = 1- E H F H : Hepatic (first pass) availability Fraction escaping elimination by the liver C in A e,b
52 Absorption and Bioavailability F F A F H Systemic circulation Bioavailability F = Fraction of D or that reaches the systemic circulation F H F A D or Gut
53 Subsystems: Isolated Perfused Organs Compartmental Isolated perfused organ Destructive sampling PBPK C(t surgery ) In vivo Cardiac output Pulmonary Transit Time Density Systemic Transit Time Density
54 Hepatic Pharmacokinetics Input Output Output Input
55 Hepatic Clearance: Sinusoidale uptake Hepatocellular metabolism Biliary excretion Cunningham & Van Horn, Alcohol Res & Health, 2003
56 Intravascular Mixing + Cellular Distribution Stochastic model of transit time distribution Advection-Dispersion Equation Microcirculatory network Intravascular mixing (vascular marker) Microscopic volume element V T tissue Cellular distribution Capillary flow V p vascular phase Weiss & Roberts, J Pharmacokin Biopharm, 1996
57 Single Capillary Extravascular Space Intravascular Space
58 k e Well-mixed cellular k in k out Disse space Vascular k off Cell k on V C k e Slow binding Rapid diffusion k in k out L d k e Slow diffusion Rapid binding d L 2 D eff Diffusion time constant k in k out Weiss et al., Br J Pharmacol, 2000
59 Hepatic Transt Time Density of Diclofenac Isolated perfused rat liver outflow curve 10 3 Slow binding 10 2 Well-mixed (cellular) Time (s) Weiss et al., Br J Pharmacol, 2000.
60 Slow Intracellular Carrier Diffusion The free fraction is negligibly small (hydrophobic and amphipatic molecules) soluble cytoplasmic binding proteins act as diffusing transport carriers (D mob ) Albumin (solid line) or [ 14 C]sucrose (dotted line) as the extracellular reference for [ 3 H]palmitate fits of the slow-diffusion model Flow Diffusion, d k in Well-mixed model (dash-dotted line) Slow-binding model (short dashed line) Slow-diffusion/bound model (solid line) Hung et al., Am J Physiol Gastrointest Liver, 2003 Luxon & Weisiger, Am J Physiol, 1993
61 Functional Characterization of Transporters Nonlinear system Flow C(t) k in Multidrug resistance associated protein (MRP) Organic cation transporter (OCT) Organic anion transporter (OAT) Organic anion transporting polypeptide (OATP) sodium-taurocholate cotransporting polypeptide (NTCP) P-glycoprotein (MDR1), Breast cancer resistance protein (BCRP) Bile salt export pump (BSEP) k in K M Vmax C( t)
62 Na pump 4 6 vascular Digoxin Semidistributed liver model Blood flow k in (C) OATP2 Hepatocyte k in ( C) V K M max C k on (C) k out k e Vascular space k off Disse space Weiss et al., Pharm Res, 2010
63 Veins Arteries Lung ICG Kinetics in Dog Brain Heart Kidney Testes Fat Muscle Liver Gut Spleen Lumping Cardiac output Pulmonary Transit Time Density Systemic Transit Time Density Pancrea s Skin Carcass Elimination Uptake LLl Liver Gut Distributed liver model Rest Systemic Weiss et al., Eur J Pharm Sci, 2011
64 Interplay between Hepatic Uptake and Excretion of ICG CL (ml/min) CL uptake (ml/min) k e (min -1 ) Weiss et al., Eur J Pharm Sci, 2011
65 Digoxin concentration (ng/ml) Question 4 Frequency of blood sampling proportional to the rate of change in blood concentration? Time(h)
66 Design of Experiments Picasso The goat Statistics formal Modelling ( Art ) informal intuitive
67 Modelling Art is the lie that helps us see the truth, said Picasso, and the same can be said of modelling. On seeing a Picasso sculpture of a goat, we are amazed that his caricature seems more goatlike than the real animal, and we gain a much stronger feeling for goatness. Similarly, a good mathematical model though distorted and hence wrong like any simplified representation of reality will reveal some essential components of a complex phenomenon. Lee A. Segel, 1984
68 Design of PK Experiments informal intuitive Experience in PK/PD formal mathematical System theory/statistics Identifiability Optimal sampling Models and Modelling
69 Information from Experiments Amount of information ~ log(1/p) p probability (expectation) of the result before the experiment is done Model without model we have no expectations: no basis for choosing what to observe, i.e., design of experiments; an observation generates an infinite amount of information Rescicno and Beck, 1987
70 A priori identifiability Given the structure of the model and experimental design, can the model parameters be estimated if the data are error free? A posteriori identifiability Given model and measured experimental data, can the model parameters be estimated within a reasonable degree of statistical precision?
71 Model misspecification Biased parameter estimates, wrong conclusions Misspecified models can give very precise estimates of the wrong answer. (Halloran et al., 1996) Model identifiability Additional information (data): e.g. on vascular mixing (MID), Fit to low and high dose responses (nonlinear systems) Bayesian estimation, a priori information
72 Issues in Experimental Design Model appropriateness A priori identifiability A posteriori identifiability Input location and duration Output (sampling) location Number, range and spacing of sample times Number of subjects
73 Choice of drug input function? Choice of route of administration Choice of sampling site Choice of sampling scheme Population or individual analysis
74 Model identification complexity reduction Model misspecification Model validity biased estimates modelling objectives
75 The art of asking the right questions in mathematics is more important than the art of solving them. Georg Cantor
76 References Avram, M. J. and T. C. Krejcie (2003). "Using front-end kinetics to optimize target-controlled drug infusions." Anesthesiology 99(5): Bjorkman, S., R. D. Wada, et al. (1998). "Application of physiologic models to predict the influence of changes in body composition and blood flows on the pharmacokinetics of fentanyl and alfentanil in patients." Anesthesiology 88(3): Cobelli, C. and E. Carson (2008). Introduction to modeling in physiology and medicine, Academic Press. Cunningham, C. C. and C. G. Van Horn (2003). "Energy availability and alcohol-related liver pathology." Alcohol Research and Health 27: Hung, D. Y., F. J. Burczynski, et al. (2003). "Fatty acid binding protein is a major determinant of hepatic pharmacokinetics of palmitate and its metabolites." American Journal of Physiology-Gastrointestinal and Liver Physiology 284(3): G423-G433. Rescigno, A., J. S. Beck, et al. (1987). "The use and abuse of models." Journal of Pharmacokinetics and Pharmacodynamics 15(3): Schalla, M. and M. Weiss (1999). "Pharmacokinetic curve fitting using numerical inverse Laplace transformation." European journal of pharmaceutical sciences 7(4): Weiss, M., G. Hübner, et al. (1996). "Effects of cardiac output on disposition kinetics of sorbitol: recirculatory modelling." British journal of clinical pharmacology 41(4): Weiss, M., T. C. Krejcie, et al. (2011). "A physiologically based model of hepatic ICG clearance: Interplay between sinusoidal uptake and biliary excretion." European Journal of Pharmaceutical Sciences 44(3): Weiss, M., P. Li, et al. (2010). "An improved nonlinear model describing the hepatic pharmacokinetics of digoxin: evidence for two functionally different uptake systems and saturable binding." Pharmaceutical research 27(9): Weiss, M. and M. S. Roberts (1996). "Tissue distribution kinetics as determinant of transit time dispersion of drugs in organs: application of a stochastic model to the rat hindlimb." Journal of pharmacokinetics and biopharmaceutics 24(2):
The general concept of pharmacokinetics
The general concept of pharmacokinetics Hartmut Derendorf, PhD University of Florida Pharmacokinetics the time course of drug and metabolite concentrations in the body Pharmacokinetics helps to optimize
More informationNonlinear pharmacokinetics
5 Nonlinear pharmacokinetics 5 Introduction 33 5 Capacity-limited metabolism 35 53 Estimation of Michaelis Menten parameters(v max andk m ) 37 55 Time to reach a given fraction of steady state 56 Example:
More informationModelling a complex input process in a population pharmacokinetic analysis: example of mavoglurant oral absorption in healthy subjects
Modelling a complex input process in a population pharmacokinetic analysis: example of mavoglurant oral absorption in healthy subjects Thierry Wendling Manchester Pharmacy School Novartis Institutes for
More informationMulticompartment Pharmacokinetic Models. Objectives. Multicompartment Models. 26 July Chapter 30 1
Multicompartment Pharmacokinetic Models Objectives To draw schemes and write differential equations for multicompartment models To recognize and use integrated equations to calculate dosage regimens To
More informationNoncompartmental vs. Compartmental Approaches to Pharmacokinetic Data Analysis Paolo Vicini, Ph.D. Pfizer Global Research and Development David M.
Noncompartmental vs. Compartmental Approaches to Pharmacokinetic Data Analysis Paolo Vicini, Ph.D. Pfizer Global Research and Development David M. Foster., Ph.D. University of Washington October 28, 2010
More informationHandling parameter constraints in complex/mechanistic population pharmacokinetic models
Handling parameter constraints in complex/mechanistic population pharmacokinetic models An application of the multivariate logistic-normal distribution Nikolaos Tsamandouras Centre for Applied Pharmacokinetic
More informationNoncompartmental vs. Compartmental Approaches to Pharmacokinetic Data Analysis Paolo Vicini, Ph.D. Pfizer Global Research and Development David M.
Noncompartmental vs. Compartmental Approaches to Pharmacokinetic Data Analysis Paolo Vicini, Ph.D. Pfizer Global Research and Development David M. Foster., Ph.D. University of Washington October 18, 2012
More informationPHARMACOKINETIC DERIVATION OF RATES AND ORDERS OF REACTIONS IN MULTI- COMPARTMENT MODEL USING MATLAB
IJPSR (2016), Vol. 7, Issue 11 (Research Article) Received on 29 May, 2016; received in revised form, 07 July, 2016; accepted, 27 July, 2016; published 01 November, 2016 PHARMACOKINETIC DERIVATION OF RATES
More informationPHA 4123 First Exam Fall On my honor, I have neither given nor received unauthorized aid in doing this assignment.
PHA 4123 First Exam Fall 1998 On my honor, I have neither given nor received unauthorized aid in doing this assignment. TYPED KEY Name Question 1. / pts 2. /2 pts 3. / pts 4. / pts. / pts 6. /10 pts 7.
More informationNa Li, PhD. Application of a Fluorescent Substrate / Inside-Out Transporter Vesicle Assay for Identifying Inhibitors of MRP Transport
Application of a Fluorescent Substrate / Inside-Out Transporter Vesicle Assay for Identifying Inhibitors of MRP Transport Na Li, PhD BD Biosciences October 20, 2010 BD Gentest Transporter Seminar Series
More informationbased prediction algorithm for tissue to plasma partition coefficients
Development of a correlation based and a decision tree based prediction algorithm for tissue to plasma partition coefficients by Yejin Yun A thesis presented to the University of Waterloo in fulfillment
More informationPHYSIO-CHEMICAL PROPERTIES OF THE DRUG. It is the interaction of the drug with its environment
PYSIO-CEMICAL PROPERTIES OF TE DRUG It is the interaction of the drug with its environment Reducing the complexity Biological process in drug action Dissolution of drug in gastrointestinal fluids Absorption
More informationMODELING THE ABSORPTION, CIRCULATION, AND METABOLISM OF TIRAPAZAMINE
MODELING THE ABSORPTION, CIRCULATION, AND METABOLISM OF TIRAPAZAMINE Olivia Nguyen and Xiaoyu Shi Problem Statement: Tirapazamine (TPZ; 1,2,4-benzotriazin-3-amine 1,4-dioxide) is a hypoxia-activated prodrug
More informationACTIVE TRANSPORT AND GLUCOSE TRANSPORT. (Chapter 14 and 15, pp and pp )
ACTIVE TRANSPORT AND GLUCOSE TRANSPORT (Chapter 14 and 15, pp 140-143 and pp 146-151) Overview Active transport is the movement of molecules across a cell membrane in the direction against their concentration
More informationRenal perfusion measurement with Ultrasound Contrast Agents. Emilio Quaia. Department of Radiology University of Trieste
Renal perfusion measurement with Ultrasound Contrast Agents Emilio Quaia Department of Radiology University of Trieste Basics of Ultrasound Contrast Agents 1. Chemicals 2. Physics 3. Pharmacokinetics 4.
More informationEvidence for the Existence of Non-monotonic Dose-response: Does it or Doesn t it?
Evidence for the Existence of Non-monotonic Dose-response: Does it or Doesn t it? Scott M. Belcher, PhD University of Cincinnati Department of Pharmacology and Cell Biophysics Evidence for the Existence
More informationGI Simulation Methods
Gastrointestinal Simulation Based on the Advanced Compartmental Absorption and Transit (ACAT) Michael B. Bolger, Ph.D. Founding Scientist Simulations Plus, Inc. GI Simulation Methods Dispersion Model Ho,
More informationMembranes 2: Transportation
Membranes 2: Transportation Steven E. Massey, Ph.D. Associate Professor Bioinformatics Department of Biology University of Puerto Rico Río Piedras Office & Lab: NCN#343B Tel: 787-764-0000 ext. 7798 E-mail:
More informationAkaike, H. (1974). A new look at the statistical model identification. IEEE Trans. Automat. Contr., 19:
Bibliography Akaike, H. (1974). A new look at the statistical model identification. IEEE Trans. Automat. Contr., 19:716 723. Barlow, R. E. und Proschan, F. (1978). Statistische Theorie der Zuverlässigkeit
More informationQuantitative Pooling of Michaelis-Menten Equations in Models with Parallel Metabolite Formation Paths
Journal of Pharmacokinetics and Biopharmaceutics, Vol. 2, No. 2, I974 Quantitative Pooling of Michaelis-Menten Equations in Models with Parallel Metabolite Formation Paths Allen J. Sedman ~ and John G.
More informationNonparametric Bayes approach for a semimechanistic pharmacodynamic model
University of New Mexico UNM Digital Repository Mathematics & Statistics ETDs Electronic Theses and Dissertations 6-23-2015 Nonparametric Bayes approach for a semimechanistic pharmacokinetic and pharmacodynamic
More informationAdvanced Higher Biology. Unit 1- Cells and Proteins 2c) Membrane Proteins
Advanced Higher Biology Unit 1- Cells and Proteins 2c) Membrane Proteins Membrane Structure Phospholipid bilayer Transmembrane protein Integral protein Movement of Molecules Across Membranes Phospholipid
More informationUnit code: K/503/1682 QCF level: 4 Credit value: 15
Unit 10: Anatomy and Physiology Unit code: K/503/1682 QCF level: 4 Credit value: 15 Aim This unit aims to develop learner understanding of physical support and movement in animals, body transport systems,
More informationValidation of the GastroPlus TM Software Tool and Applications
Validation of the GastroPlus TM Software Tool and Applications Fagen Zhang and Leah Luna The Dow Chemical Company FZ/MB 01.11.11 Acknowledgements Michael Bartels Barun Bhhatarai (Novartis) Tyler Auernhammer
More informationReaction Rate (Kinetics) Reaction Rate
Instructor: Allan Felsot afelsot@tricity.wsu.edu Fall 2 Reaction Rate (Kinetics) ES/RP 3 Fundamentals of Environmental Toxicology Lecture / Pharmacokinetics (Toxicokinetics) & Pharmacodynamics (Toxicodynamics)
More informationPhysical-Chemistry Factors Affecting Oral Absorption. Objectives. ph - Partition Theory. 27 September Chapter 23 1
Physical-Chemistry Factors Affecting Oral Absorption Objectives Understand the physical-chemical factors that affect oral absorption Understand the ph-partition hypothesis as it applies to drug absorption
More informationBiotransport: Principles
Robert J. Roselli Kenneth R. Diller Biotransport: Principles and Applications 4 i Springer Contents Part I Fundamentals of How People Learn (HPL) 1 Introduction to HPL Methodology 3 1.1 Introduction 3
More informationPhysiology. Organization of the Body. Assumptions in Physiology. Chapter 1. Physiology is the study of how living organisms function
Introduction to Physiology and Homeostasis Chapter 1 Physiology Physiology is the study of how living organisms function On the street explanations are in terms of meeting a bodily need Physiologic explanations
More informationOn drug transport after intravenous administration
On drug transport after intravenous administration S.Piekarski (1), M.Rewekant (2) Institute of Fundamental Technological Research Polish Academy of Sciences (1), Medical University of Warsaw, Poland Abstract
More informationMetabolic system dynamics: lumped and distributed models
Metabolic system dynamics: lumped and distributed models G.M. Saidel 1,2, J.A. DiBella II 1 & M.E. Cabrera 1,2,3 1 Department of Biomedical Engineering, Case Western Reserve University Cleveland, OH, USA
More informationPHAR 7633 Chapter 12 Physical-Chemical Factors Affecting Oral Absorption
PHAR 7633 Chapter 12 Physical-Chemical Factors Affecting Oral Absorption Physical-Chemical Factors Affecting Oral Absorption Student Objectives for this Chapter After completing the material in this chapter
More informationAPPLICATION OF LAPLACE TRANSFORMS TO A PHARMACOKINETIC OPEN TWO-COMPARTMENT BODY MODEL
Acta Poloniae Pharmaceutica ñ Drug Research, Vol. 74 No. 5 pp. 1527ñ1531, 2017 ISSN 0001-6837 Polish Pharmaceutical Society APPLICATION OF LAPLACE TRANSFORMS TO A PHARMACOKINETIC OPEN TWO-COMPARTMENT BODY
More informationMembrane transport 1. Summary
Membrane transport 1. Summary A. Simple diffusion 1) Diffusion by electrochemical gradient no energy required 2) No channel or carrier (or transporter protein) is needed B. Passive transport (= Facilitated
More informationIntroduction to PK/PD modelling - with focus on PK and stochastic differential equations
Downloaded from orbit.dtu.dk on: Feb 12, 2018 Introduction to PK/PD modelling - with focus on PK and stochastic differential equations Mortensen, Stig Bousgaard; Jónsdóttir, Anna Helga; Klim, Søren; Madsen,
More informationEndocrine Physiology. Introduction to Endocrine Principles
Endocrine Physiology Introduction to Endocrine Principles There are TWO major groups of hormones Peptide and protein hormones Amine hormones Peptide and protein hormones act through cell membrane receptors
More informationPredicting the Onset of Nonlinear Pharmacokinetics
Citation: CPT Pharmacometrics Syst Pharmacol (208) 7, 670 677; doi:0002/psp4236 ARTICLE Predicting the Onset of Nonlinear Pharmacokinetics Andrew M Stein and Lambertus A Peletier 2 When analyzing the pharmacokinetics
More informationHow Critical is the Duration of the Sampling Scheme for the Determination of Half-Life, Characterization of Exposure and Assessment of Bioequivalence?
How Critical is the Duration of the Sampling Scheme for the Determination of Half-Life, Characterization of Exposure and Assessment of Bioequivalence? Philippe Colucci 1,2 ; Jacques Turgeon 1,3 ; and Murray
More informationLecture 22: PHARMACY CALCULATIONS for Technicians Preparing Injectable Medications
Lecture 22: PHARMACY CALCULATIONS for Technicians Preparing Injectable Medications PHARMACY CALCULATIONS for Technicians Preparing Injectable Medications This chapter provides an overview of how to determine
More informationSchémata zpracovalo Servisní středisko pro e-learning na MU
Schémata zpracovalo Servisní středisko pro e-learning na MU http://is.muni.cz/stech/ Life is a dynamic system with focused behavior, with autoreproduction, characterized by flow of substrates, energies
More informationCELL BIOLOGY - CLUTCH CH. 9 - TRANSPORT ACROSS MEMBRANES.
!! www.clutchprep.com K + K + K + K + CELL BIOLOGY - CLUTCH CONCEPT: PRINCIPLES OF TRANSMEMBRANE TRANSPORT Membranes and Gradients Cells must be able to communicate across their membrane barriers to materials
More informationIDENTIFICATION OF PARAMETERS FOR HILL CURVE USED IN GENERAL ANESTHESIA
IDENTIFICATION OF PARAMETERS FOR HILL CURVE USED IN GENERAL ANESTHESIA Diego F. Sendoya-Losada Department of Electronic Engineering, Faculty of Engineering, Surcolombiana University, Neiva, Huila, Colombia
More informationTK Solver Case Study: Pharmacokinetics
TK Solver Case Study: Pharmacokinetics The content for this example was provided by Professor Prasad Dhurjati of the University of Delaware. It is used there in the class Applied Mathematics for Chemical
More informationABC Transporter Vesicle Assay: Comparison of Cold (LC-MS/MS) and Hot (Radiolabeled) Methods. Na Li, PhD. BD Biosciences Discovery Labware May 29, 2012
ABC Transporter Vesicle Assay: Comparison of Cold (LC-MS/MS) and Hot (Radiolabeled) Methods Na Li, PhD BD Biosciences Discovery Labware May 29, 212 Today s Topics Overview of the important role of ABC
More informationUnit 1: Cells, Tissues, Organs, and Systems
Unit 1: Cells, Tissues, Organs, and Systems Big Ideas The cell is the basic scientific unit of all living things. Cells must interact with the external environment to meet their basic needs. Your health
More informationPassaic County Technical Institute. Wayne, NJ. Anatomy and Physiology II Curriculum. August 2015
Passaic County Technical Institute Wayne, NJ Anatomy and Physiology II Curriculum August 2015 Anatomy and Physiology II Curriculum August 2015 I. Course Description Anatomy and Physiology II is a full
More informationLABETTE COMMUNITY COLLEGE BRIEF SYLLABUS. ANATOMY AND PHYSIOLOGY, lecture and lab
LABETTE COMMUNITY COLLEGE BRIEF SYLLABUS SPECIAL NOTE: This brief syllabus is not intended to be a legal contract. A full syllabus will be distributed to students at the first class session. TEXT AND SUPPLEMENTARY
More informationDynamic Contrast Enhance (DCE)-MRI
Dynamic Contrast Enhance (DCE)-MRI contrast enhancement in ASL: labeling of blood (endogenous) for this technique: usage of a exogenous contras agent typically based on gadolinium molecules packed inside
More informationBasic Concepts in Population Modeling, Simulation, and Model-Based Drug Development Part 2: Introduction to Pharmacokinetic Modeling Methods
Tutorial Citation: CPT: Pharmacometrics & Systems Pharmacology (3), e38; doi:.38/psp.3.4 3 ASCPT All rights reserved 63-836/ www.nature.com/psp Basic Concepts in Population Modeling, Simulation, and Model-Based
More informationBeka 2 Cpt: Two Compartment Model - Loading Dose And Maintenance Infusion
MEDSCI 719 Pharmacometrics Beka 2 Cpt: Two Compartment Model - Loading Dose And Maintenance Infusion Objective 1. To observe the time course of drug concentration in the central and peripheral compartments
More informationF. Combes (1,2,3) S. Retout (2), N. Frey (2) and F. Mentré (1) PODE 2012
Prediction of shrinkage of individual parameters using the Bayesian information matrix in nonlinear mixed-effect models with application in pharmacokinetics F. Combes (1,2,3) S. Retout (2), N. Frey (2)
More informationAnatomy and Physiology. Science Curriculum Framework
Anatomy and Physiology Science Curriculum Framework Revised 005 Anatomy and Physiology Anatomy and Physiology should develop an understanding of the organization of the human body through studies of body
More informationPrinciples of Drug Design
Advanced Medicinal Chemistry II Principles of Drug Design Tentative Course Outline Instructors: Longqin Hu and John Kerrigan Direct questions and enquiries to the Course Coordinator: Longqin Hu I. Introduction
More informationSpectral analysis: principle and clinical applications
REVIEW Annals of Nuclear Medicine Vol. 17, No. 6, 427 434, 2003 Spectral analysis: principle and clinical applications Kenya MURASE Department of Medical Physics and Engineering, Division of Medical Technology
More informationIntroduction to electrophysiology. Dr. Tóth András
Introduction to electrophysiology Dr. Tóth András Topics Transmembran transport Donnan equilibrium Resting potential Ion channels Local and action potentials Intra- and extracellular propagation of the
More informationFlow of information in a drug discovery pipeline. 7th lecture Modern Methods in Drug Discovery WS16/17 1
Flow of information in a drug discovery pipeline 7th lecture Modern Methods in Drug Discovery WS16/17 1 eadmet prediction early Absorption Distribution Metabolism Elimination Toxicology Pharmacokinetic
More informationIntegration of SAS and NONMEM for Automation of Population Pharmacokinetic/Pharmacodynamic Modeling on UNIX systems
Integration of SAS and NONMEM for Automation of Population Pharmacokinetic/Pharmacodynamic Modeling on UNIX systems Alan J Xiao, Cognigen Corporation, Buffalo NY Jill B Fiedler-Kelly, Cognigen Corporation,
More informationDelivery. Delivery Processes. Delivery Processes: Distribution. Ultimate Toxicant
Delivery Ultimate Toxicant The chemical species that reacts with the endogenous target. Toxicity depends on the concentration (dose) of the ultimate toxicant at the target site Delivery Processes Absorption
More informationThere should be nothing new for you in this lecture. If there is, stay for office hours and / or ask for help from the TAs.
Membranes 02 The goal of this lecture is to review pre-requisite material related to the structure and function of biological membranes and to provide students a further overview of material to be covered
More informationUsing ODEs to Model Drug Concentrations within the Field of Pharmacokinetics
Augustana College Augustana Digital Commons Mathematics: Student Scholarship & Creative Works Mathematics Spring 2016 Using ODEs to Model Drug Concentrations within the Field of Pharmacokinetics Andrea
More informationFRAUNHOFER IME SCREENINGPORT
FRAUNHOFER IME SCREENINGPORT Design of screening projects General remarks Introduction Screening is done to identify new chemical substances against molecular mechanisms of a disease It is a question of
More informationBiophysics I. DIFFUSION
Biophysics I. DIFFUSION Experiment add a droplet of ink to a glass of water Observation: the stain spreads and eventually colours the entire fluid add a droplet of ink to HOT and COLD water Observation:
More informationOverview of Physiology & Homeostasis. Biological explanations Levels of organization Homeostasis
Overview of Physiology & Homeostasis 1 Biological explanations Levels of organization Homeostasis 2 Biological Explanations Proximate Proximate causation: an explanation of an animal's behavior based on
More informationAdvanced Anatomy and Physiology
Lakeshore Technical College 10806179 Advanced Anatomy and Physiology Course Outcome Summary Course Information Alternate Title Description Total Credits 4 Total Hours 90 Adv Anatomy & Physiology Advanced
More informationSaba Al Fayoumi. Tamer Barakat. Dr. Mamoun Ahram + Dr. Diala Abu-Hassan
1 Saba Al Fayoumi Tamer Barakat Dr. Mamoun Ahram + Dr. Diala Abu-Hassan What is BIOCHEMISTRY??? Biochemistry = understanding life Chemical reactions are what makes an organism (An organism is simply atoms
More informationCompartmental Modelling: Eigenvalues, Traps and Nonlinear Models
Compartmental Modelling: Eigenvalues, Traps and Nonlinear Models Neil D. Evans neil.evans@warwick.ac.uk School of Engineering, University of Warwick Systems Pharmacology - Pharmacokinetics Vacation School,
More informationNumerical Simulations of Stochastic Circulatory Models
Bulletin of Mathematical Biology (1999) 61, 365 377 Article No. bulm.1998.94 Available online at http://www.idealibrary.com on Numerical Simulations of Stochastic Circulatory Models Gejza Wimmer Mathematical
More informationPROPERTIES OF SOLUTIONS A S S T. P R O F. D R. A L A A J. M A H R A T H M E D I C A L C H E M I S T R Y
PROPERTIES OF SOLUTIONS A S S T. P R O F. D R. A L A A J. M A H R A T H M E D I C A L C H E M I S T R Y LEARNING GOAL Identify a mixture as a solution, a colloid, or a suspension. Describe how the number
More informationBasic Principles of Tracer Kinetic Modelling
The Spectrum of Medical Imaging Basic Principles of Tracer Kinetic Modelling Adriaan A. Lammertsma Structure X-ray/CT/MRI Physiology US, SPECT, PET, MRI/S Metabolism PET, MRS Drug distribution PET Molecular
More informationCorrection of the likelihood function as an alternative for imputing missing covariates. Wojciech Krzyzanski and An Vermeulen PAGE 2017 Budapest
Correction of the likelihood function as an alternative for imputing missing covariates Wojciech Krzyzanski and An Vermeulen PAGE 2017 Budapest 1 Covariates in Population PKPD Analysis Covariates are defined
More information3 Results. Part I. 3.1 Base/primary model
3 Results Part I 3.1 Base/primary model For the development of the base/primary population model the development dataset (for data details see Table 5 and sections 2.1 and 2.2), which included 1256 serum
More informationCurrent approaches to covariate modeling
Current approaches to covariate modeling Douglas J. Eleveld, Ph.D., Assistant Professor University of Groningen, University Medical Center Groningen, Department of Anesthesiology, Groningen, The Netherlands
More informationOn approximate solutions in pharmacokinetics
On separation of time scales in pharmacokinetics Piekarski S, Rewekant M. IPPT PAN, WUM Abstract A lot of criticism against the standard formulation of pharmacokinetics has been raised by several authors.
More informationAn Approach for Identifiability of Population Pharmacokinetic-Pharmacodynamic Models
An Approach for Identifiability of Population Pharmacokinetic-Pharmacodynamic Models Vittal Shivva 1 * Julia Korell 12 Ian Tucker 1 Stephen Duffull 1 1 School of Pharmacy University of Otago Dunedin New
More informationIntroduction to electrophysiology 1. Dr. Tóth András
Introduction to electrophysiology 1. Dr. Tóth András Topics Transmembran transport Donnan equilibrium Resting potential Ion channels Local and action potentials Intra- and extracellular propagation of
More informationName # Class Date Regents Review: Cells & Cell Transport
Name # Class Date Regents Review: Cells & Cell Transport 1. All of the following are true regarding cells except? A) All cells have genetic material B) All cells have cell walls C) All cells have plasma
More informationAlkalosis or alkalemia arterial blood ph rises above Acidosis or acidemia arterial ph drops below 7.35 (physiological acidosis)
Acid-Base Balance Normal ph of body fluids Arterial blood is 7.4 Venous blood and interstitial fluid is 7.35 Intracellular fluid is 7.0 Alkalosis or alkalemia arterial blood ph rises above 7.45 Acidosis
More informationChapt. 12, Movement Across Membranes. Chapt. 12, Movement through lipid bilayer. Chapt. 12, Movement through lipid bilayer
Chapt. 12, Movement Across Membranes Two ways substances can cross membranes Passing through the lipid bilayer Passing through the membrane as a result of specialized proteins 1 Chapt. 12, Movement through
More informationKinetic Modeling for Vesicle Drug Delivery to the Liver
Kinetic Modeling for Vesicle Drug Delivery to the Liver Michael Liao CJ Norsigian Michael Salazar October 5, 2016 Contents Introduction...... 3 Hepatic Receptor Study... 4 Problem Statement... 5 Methods.
More informationASSESSING THE DRUG ABILITY OF CHALCONES USING IN- SILICO TOOLS
Page109 IJPBS Volume 5 Issue 1 JAN-MAR 2015 109-114 Research Article Pharmaceutical Sciences ASSESSING THE DRUG ABILITY OF CHALCONES USING IN- SILICO TOOLS Department of Pharmaceutical Chemistry, Institute
More informationIntroduction to electrophysiology 1. Dr. Tóth András
Introduction to electrophysiology 1. Dr. Tóth András Today topics Transmembran transport Donnan equilibrium Resting potential Level of significance Entry level (even under 6) Student level (for most of
More informationMembrane Protein Pumps
Membrane Protein Pumps Learning objectives You should be able to understand & discuss: Active transport-na + /K + ATPase ABC transporters Metabolite transport by lactose permease 1. Ion pumps: ATP-driven
More informationTomography is imaging by sections. 1
Tomography is imaging by sections. 1 It is a technique used in clinical medicine and biomedical research to create images that show how certain tissues are performing their physiological functions. 1 Conversely,
More informationEast Poinsett County School District Anatomy and Physiology Curriculum Guide Revised August 2011
East Poinsett County School District Anatomy and Physiology Curriculum Guide Revised August 0 Ongoing Strand: Nature of Science Standard 6: Students shall demonstrate an understanding that science is a
More informationAuthor's personal copy. Mathematical and Computer Modelling
Mathematical and Computer Modelling 50 (2009) 959 974 Contents lists available at ScienceDirect Mathematical and Computer Modelling journal homepage: www.elsevier.com/locate/mcm A mathematical model for
More informationPractical: Acid-base balance
Practical: Acid-base balance Definition All the processes inside the body which keep the H+ concentration within normal values. It is a result of the hydro-electrolytic balance and a sum of mechanisms
More informationPlant and animal cells (eukaryotic cells) have a cell membrane, cytoplasm and genetic material enclosed in a nucleus.
4.1 Cell biology Cells are the basic unit of all forms of life. In this section we explore how structural differences between types of cells enables them to perform specific functions within the organism.
More informationCh. 3: Cells & Their Environment
Ch. 3: Cells & Their Environment OBJECTIVES: 1. Understand cell membrane permeability 2. To recognize different types of cellular transport (passive vs active) 3. To understand membrane potential and action
More informationModeling Airflow and Particle Deposition in the Lung Bahman Asgharian
Modeling Airflow and Particle Deposition in the Lung Bahman Asgharian Health Effects and Medical Response Applied Research Associates Raleigh, NC U.S.A. Lung Deposition Modeling Develop models based on
More informationPrediction of Oral Absorption: 6-Fluoroquinolones
Prediction of ral Absorption: 6-luoroquinolones Mª del Val Bermejo Sanz, Ph.D. Depto. armacia y Tecnología armacéutica acultad de armacia. Universidad de Valencia Valencia, España Strategies for ral Drug
More informationPhysiology Coloring Book: Panels 29, 32, 33,
ELEC4623/ELEC9734: Semester 2, 2009 Dr Stephen Redmond School of Electrical Engineering & Telecommunications Email: s.redmond@unsw.edu.au Ph: 9385 6101 Rm: 458, ELECENG (G17) Physiology Coloring Book:
More informationAntibiotic efflux pumps in eucaryotic cells: consequences for activity against intracellular bacteria
Antibiotic efflux pumps in eucaryotic cells: consequences for activity against intracellular bacteria Françoise Van Bambeke on behalf of J.M. Michot, C. Seral, M. Heremans, M.P. Mingeot-Leclercq, P.M.
More informationHow Chemicals Move Into, Around & Out of the Body ENV
How Chemicals Move Into, Around & Out of the Body 1 ADME The movement of toxicants into, around and out of the body is commonly referred to as ADME! Absorption! Distribution! Metabolism! Elimination 2
More informationA Novel Screening Method Using Score Test for Efficient Covariate Selection in Population Pharmacokinetic Analysis
A Novel Screening Method Using Score Test for Efficient Covariate Selection in Population Pharmacokinetic Analysis Yixuan Zou 1, Chee M. Ng 1 1 College of Pharmacy, University of Kentucky, Lexington, KY
More informationMembrane Physiology. Dr. Hiwa Shafiq Oct-18 1
Membrane Physiology Dr. Hiwa Shafiq 22-10-2018 29-Oct-18 1 Chemical compositions of extracellular and intracellular fluids. 29-Oct-18 2 Transport through the cell membrane occurs by one of two basic processes:
More informationCELL PRACTICE TEST
Name: Date: 1. As a human red blood cell matures, it loses its nucleus. As a result of this loss, a mature red blood cell lacks the ability to (1) take in material from the blood (2) release hormones to
More informationIntroduction to Statistical Population Modeling and Analysis for Pharmacokinetic Data
Introduction to Statistical Population Modeling and Analysis for Pharmacokinetic Data Marie Davidian Department of Statistics, North Carolina State University Raleigh, North Carolina 27695-8203, U.S.A.
More informationIntroduction to cardiac electrophysiology 1. Dr. Tóth András 2018
Introduction to cardiac electrophysiology 1. Dr. Tóth ndrás 2018 Topics Transmembran transport Donnan equilibrium Resting potential 1 Transmembran transport Major types of transmembran transport J: net
More informationHEMATOLOGY/ HEMATOPOIESIS. Introduction
HEMATOLOGY/ HEMATOPOIESIS Introduction HEMATOLOGY Introduction Study of blood & its components Window of rest of body BLOOD Raison d etre Delivery of nutrients Oxygen Food Vitamins Removal of wastes Carbon
More informationCOMPUTER AIDED DRUG DESIGN (CADD) AND DEVELOPMENT METHODS
COMPUTER AIDED DRUG DESIGN (CADD) AND DEVELOPMENT METHODS DRUG DEVELOPMENT Drug development is a challenging path Today, the causes of many diseases (rheumatoid arthritis, cancer, mental diseases, etc.)
More informationEarly Stages of Drug Discovery in the Pharmaceutical Industry
Early Stages of Drug Discovery in the Pharmaceutical Industry Daniel Seeliger / Jan Kriegl, Discovery Research, Boehringer Ingelheim September 29, 2016 Historical Drug Discovery From Accidential Discovery
More information